Showing results (471-480 of 1,047) with videos related to

Sort By:
Pageof 105
Drug Discoveries & Therapeutics|June 26, 2025
Kampo medicine in the management of menopausal symptoms: A narrative review of therapeutic potentialYuanzheng Liu, Susumu Kobayashi, Ling Wang, et al.
Drug Discoveries & Therapeutics|December 22, 2024
Acupuncture and Bushen Quyu decoction improved endometrial receptivity, hormone secretion, and uterine artery blood flow for repeated implantation failure patients undergoing in vitro fertilization and embryo transferQi Zhou, Lina Song, Jiahui Ma, et al.
Drug Discoveries & Therapeutics|December 22, 2024
Agarwood as a potential therapeutic for Alzheimer's disease: Mechanistic insights and target identificationYa-Nan Ma, Xiqi Hu, Kenji Karako, et al.
Drug Discoveries & Therapeutics|February 26, 2025
Characteristics and patterns of adverse event reports in the Japanese Adverse Drug Event Report database over two decades (2004-2023): Exploring findings on sexes and age groupsHiroyuki Tanaka, Masaki Takigawa, Naohito Ide, et al.
Drug Discoveries & Therapeutics|February 26, 2025
Isolation and characterization of phosphoglycerate kinase and creatine kinase from bighead carp (Aristichthys nobilis): Potential sources for antitumor agentsYue Gao, Wanying Liu, Qing Yan, et al.
Drug Discoveries & Therapeutics|February 26, 2025
Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute painShasha Hu, Dong Lyu, Jianjun Gao
Drug Discoveries & Therapeutics|February 26, 2025
Human gut associated Bacteroides and Akkermansia bacteria exhibit immunostimulatory activity in the silkworm muscle contraction assayFumiaki Tabuchi, Chie Kano, Tatsuhiko Hirota, et al.
Drug Discoveries & Therapeutics|February 26, 2025
Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting SystemLuxuan Yang, Wenyong Zhang, Xiujuan Shen, et al.
Drug Discoveries & Therapeutics|January 5, 2025
Kampo medicine inducing drug-induced liver injury: A case report and systematic reviewAkane Hoshi, Haruki Funakoshi, Yumi Otoyama, et al.
Drug Discoveries & Therapeutics|January 5, 2025
Long-term renoprotective effect of luseogliflozin in type 2 diabetes patients: CHikushi Anti-diabetes mellitus Trial-Lusefi (CHAT-Lu)Yosuke Takamiya, Chiyori Imanaga, Ichiro Abe, et al.
Pageof 105